Skip to main content
Clinical Trials/ACTRN12605000364673
ACTRN12605000364673
Recruiting
Phase 3

The effects of nutritional supplementation on premenstrual syndrome

Swisse Bio-juven0 sites120 target enrollmentSeptember 12, 2005

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Premenstrual Syndrome
Sponsor
Swisse Bio-juven
Enrollment
120
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 12, 2005
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Swisse Bio-juven

Eligibility Criteria

Inclusion Criteria

  • 1\. Subject has a regular menstrual cycle of 25 to 35 days. 2\. Subject's general health is normal. 3\. Subject has had symptoms of PMS in the last year. 4\. Subject is willing to cease taking other supplements for the period of the trail. 5\. Subject is willing to comply with the study protocol.

Exclusion Criteria

  • 1\. Subject is currently pregnant or lactating. 2\. Subject who is of childbearing age who is not surgically sterile, who is 1\) not using effective contraception, and 2\) does not agree to have a pregnancy test monthly during the study. 3\. Subject is currently taking regular medication or dietary supplement(s) and is unwilling to cease. 4\. Subject self reports that they are experiencing undue stress/relationship problems. 5\. Subject has any significant disease or disorder. 6\. Subject is currently undergoing treatment for PMS. 7\. Subject commenced oral contraceptives in the three months prior to commencement. 8\. Subject changed oral contraceptives in the three months prior to commencement. 9\. Subject has had adverse effects from supplements and/or drugs. 10\. Subjects who are taking steroids. 11\. Subjects with parathyroid disorders. 12\. Subjects with thyroid disorders. 13\. Subjects with affective disorders. 14\. Subjects who experience photosensitive skin reactions or hypersensitivity to ginger. 15\. Any disease particularly conditions that interact with gonadotrophins or their releasing factors and those that compromise digestion or absorption of micronutrients. 16\. Any significant health complaint, problem or disease that in the opinion of the researcher would compromise the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials